The first big one is a so-called "correction," which simply means that an index -- in this case, the Nasdaq Composite-- has declined by 10% from its highs. Corrections aren't unusual at all ...
Right now, investors are clearly selling assets, but they are also looking for a new home for the cash that's raised. One ...
Q4 2024 Earnings Call Transcript March 13, 2025 Operator: Hello, and welcome to Nyxoah Fourth Quarter 2024 Earnings ...
Q4 2024 Earnings Call Transcript March 13, 2025 Akebia Therapeutics, Inc. misses on earnings expectations. Reported EPS is ...
There's nothing particularly magical about a 10% drop in a stock market index. It is just a number, like any other. But it ...
Q4 2024 Earnings Call Transcript March 13, 2025 Operator: Good day, and welcome to CPS Technologies Fourth Quarter and ...
Q4 2024 Earnings Call Transcript March 13, 2025 Lifetime Brands, Inc. beats earnings expectations. Reported EPS is $0.55, ...
Q4 2024 Earnings Call Transcript March 12, 2025 Amarin Corporation plc beats earnings expectations. Reported EPS is $-0.03, ...
Protagonist Therapeutics, Inc.'s VERIFY and ANTHEM-UC studies show breakthroughs in polycythemia vera and ulcerative colitis.
The Nasdaq has fallen into correction territory and is down more than 10%. Investors have become emotional, on both the selling and buying side of the equation. Kraft Heinz and its roughly 5% ...
Q4 2024 Earnings Call Transcript March 12, 2025 biote Corp. beats earnings expectations. Reported EPS is $0.1, expectations ...
Q4 2024 Earnings Call Transcript March 11, 2025 Allbirds, Inc. beats earnings expectations. Reported EPS is $-3.23, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results